The metaproterenol (orciprenaline) in the treatment of the symptomatic complete heart block.
D000208:Acute Disease; D000219:Adams-Stokes Syndrome / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D000368:Aged; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D006348:Cardiac Surgical Procedures; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003327:Coronary Disease / Q000150:complications; D005260:Female; D006327:Heart Block / Q000188:drug therapy*; D006330:Heart Defects, Congenital / Q000150:complications; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D010138:Pacemaker, Artificial; D010627:Phenethylamines / Q000627:therapeutic use; D011183:Postoperative Complications; D012118:Resorcinols / Q000627:therapeutic use*
D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D009921:Metaproterenol